Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 6-7, Juin–Juillet 2014
Page(s) 683 - 687
Section Forum
DOI https://doi.org/10.1051/medsci/20143006021
Publié en ligne 11 juillet 2014
  1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 ; 144 : 646–674. [CrossRef] [PubMed]
  2. Bozic I, Antal T, Ohtsuki H, et al. Accumulation of driver and passenger mutations during tumour progression. Proc Natl Acad Sci USA 2010 ; 107 : 18545–18550. [CrossRef]
  3. Versteeg R. Cancer: tumours outside the mutation box. Nature 2014 ; 506 : 438–439. [CrossRef] [PubMed]
  4. Sakaguchi H, Okuno Y, Muramatsu H, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 2013 ; 45 : 937–941. [CrossRef] [PubMed]
  5. Kandoth C, McLellan MD, Vandin F, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013 ; 502 : 333–339. [CrossRef] [PubMed]
  6. Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature 2013 ; 500 : 415–421. [CrossRef] [PubMed]
  7. Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014 ; 505 : 495–501. [CrossRef] [PubMed]
  8. Nik-Zainal S, Alexandrov LB, Wedge DC, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012 ; 149 : 979–993. [CrossRef] [PubMed]
  9. Stephens PJ, Greenman CD, Fu B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011 ; 144 : 27–40. [CrossRef] [PubMed]
  10. Norton L. A Gompertzian model of human breast cancer growth. Cancer Res 1988 ; 48 : 7067–7071. [PubMed]
  11. Luebeck EG. Cancer: genomic evolution of metastasis. Nature 2010 ; 467 : 1053–1055. [CrossRef] [PubMed]
  12. Wong TN, Ramsingh G, Young A, et al. The role of early TP53 mutations on the evolution of therapy-related AML. 55th ASH Annual Meeting, New Orleans, December 7–10, 2013, abstract 5.
  13. Breen MS, Kemena C, Vlasov PK, et al. Epistasis as the primary factor in molecular evolution. Nature 2012 ; 490 : 535–538. [CrossRef] [PubMed]
  14. Vainchenker W, Constantinescu SN. JAK/STAT signaling in hematological malignancies. Oncogene 2013 ; 32 : 2601–2613. [CrossRef] [PubMed]
  15. Patel JP, Gönen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012 ; 366 : 1079–1089. [CrossRef] [PubMed]
  16. Prahallad A, Sun C, Huang S, et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature 2012 ; 483 : 100–103. [CrossRef] [PubMed]
  17. Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013 ; 152 : 714–726. [CrossRef] [PubMed]
  18. Itzykson R, Kosmider O, Renneville A, et al. Clonal architecture of chronic myelomonocytic leukemias. Blood 2013 ; 121 : 2186–2198. [CrossRef] [PubMed]
  19. Anderson K, Lutz C, van Delft FW, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 2011 ; 469 : 356–361. [CrossRef] [PubMed]
  20. Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature 2013 ; 501 : 328–337. [CrossRef] [PubMed]
  21. Clappier E, Gerby B, Sigaux F, et al. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med 2011 ; 208 : 653–661. [CrossRef] [PubMed]
  22. Roche-Lestienne C, Soenen-Cornu V, Grardel-Duflos N, et al. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. Blood 2002 ; 100 : 1014–1018. [CrossRef] [PubMed]
  23. Klco JM, Spencer DH, Miller CA, et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell 2014 ; 25 : 379–392. [CrossRef] [PubMed]
  24. Diaz LA, Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 2014 ; 32 : 579–586. [CrossRef] [PubMed]
  25. Krebs MG, Metcalf RL, Carter L, et al. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol 2014 ; 11 : 129–144. [CrossRef] [PubMed]
  26. Jamal-Hanjani M, Thanopoulou E, Peggs KS, et al. Tumour heterogeneity and immune-modulation. Curr Opin Pharmacol 2013 ; 13 : 497–503. [CrossRef] [PubMed]
  27. Jan M, Snyder TM, Corces-Zimmerman MR, et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med 2012 ; 4 : 149ra118. [PubMed]
  28. Solary E, Bernard OA, Tefferi A, et al. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 2014 ; 28 : 485–496. [CrossRef] [PubMed]
  29. Jacobs KB, Yeager M, Zhou W, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 2012 ; 44 : 651–658. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.